FiercePharmaOriginal article
{"a":[{"_":"Swiss CDMOS making moves: Lonza bets on new US facility, CordenPharma scales injectables with €80M ","$":{"href":"/pharma/lonza-bets-complex-therapies-new-us-facility-corden-scales-injectable-capacity-500-million","hreflang":"en"}}]}
Positive
AI Analysis
Summary
Lonza is building a new spray-drying facility in Bend, Oregon, while CordenPharma is scaling injectable capacity with an €80M investment, both affirming Swiss CDMOs' commitment to expanding high-margin manufacturing capabilities.
Importance:3/10
Sentiment:
0.60
CDMOcapacity expansionmanufacturingSwitzerlandUnited States
Related Companies
Read the original article
Published by FiercePharma on September 10, 2026 12:09 PM